Document is current
Any future updates will be listed below
-
Authors
Vonficht, Dominik
Jopp-Saile, Lea
Yousefian, Schayan https://orcid.org/0000-0003-0902-0369
Flore, Viktoria https://orcid.org/0009-0001-3023-433X
Simó Vesperinas, Inés
Teuber, Ruth
Avanesyan, Bogdan https://orcid.org/0009-0004-2547-6598
Luo, Yanjiang https://orcid.org/0009-0003-0401-467X
Röthemeier, Caroline
Grünschläger, Florian https://orcid.org/0000-0003-0021-6912
Fernandez-Vaquero, Mirian
Fregona, Vincent
Ordoñez-Rueda, Diana https://orcid.org/0000-0002-8387-6707
Schmalbrock, Laura K. https://orcid.org/0000-0002-6080-6175
Deininger, Luca https://orcid.org/0009-0005-5125-6422
Yamachui Sitcheu, Angelo Jovin https://orcid.org/0009-0002-9384-6496
Gu, Zuguang
Funk, Maja C. https://orcid.org/0000-0002-6007-1164
Mikut, Ralf https://orcid.org/0000-0001-9100-5496
Heikenwälder, Mathias
Eggert, Angelika
von Stackelberg, Arend
Kobold, Sebastian https://orcid.org/0000-0002-5612-4673
Krönke, Jan
Keller, Ulrich https://orcid.org/0000-0002-8485-1958
Trumpp, Andreas
Hegazy, Ahmed N.
Eckert, Cornelia https://orcid.org/0000-0003-1039-2872
Hübschmann, Daniel https://orcid.org/0000-0002-6041-7049
Haas, Simon https://orcid.org/0000-0001-9227-2051
- License Information
-
More Information
Article History
Received: 7 March 2024
Accepted: 6 May 2025
First Online: 7 August 2025
Competing interests
: The authors declare the following competing interests: S.H., S.Y., V. Flore, I.S.V., C.E., R.T., D.H., D.V., L.J.-S. and A.T. are listed as inventors for the European Patent Application no. 24181153.8 from the Charité – Universitätsmedizin Berlin and Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (priority application filed). The patent covers the core technology and applications of the Interact-omics framework. S.K. has received honoraria from Cymab, Plectonic, TCR2 Inc., Novartis, BMS, Miltenyi and GSK. S.K. is inventor of several patents in the field of immuno-oncology. S.K. received license fees from TCR2 Inc. and Carina Biotech. D.H. owns stock from Platomics GmbH. The other authors declare no competing interests.
